Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 8Head & Neck 6Sarcoma 1Gynecologic 1Genitourinary 1Gastrointestinal 1

Conditions

Ovarian Neoplasms 57Carcinoma, Ovarian Epithelial 28Fallopian Tube Neoplasms 20Uterine Cervical Neoplasms 17Endometrial Neoplasms 17Breast Neoplasms 13Stomach Neoplasms 11Carcinoma, Non-Small-Cell Lung 11Lung Neoplasms 9Prostatic Neoplasms 8Squamous Cell Carcinoma of Head and Neck 7Parkinson Disease 4, Autosomal Dominant Lewy Body 7Esophageal Neoplasms 7Carcinoma, Renal Cell 7Peritoneal Neoplasms 6Melanoma 6Uterine Neoplasms 4Urinary Bladder Neoplasms 4Small Cell Lung Carcinoma 4Sarcoma 4Pancreatic Neoplasms 4Neoplasms 4Head and Neck Neoplasms 4Esthesioneuroblastoma, Olfactory 4Colorectal Neoplasms 4Carcinoma, Transitional Cell 4Triple Negative Breast Neoplasms 3Salivary Gland Neoplasms 3Kidney Neoplasms 3Brenner Tumor 3

Interventions

Carboplatin 19Paclitaxel 17Cisplatin 9Gemcitabine 7Cyclophosphamide 7Bevacizumab 6Topotecan 5pembrolizumab 4olaparib 4liposomal doxorubicin 4durvalumab 4Letrozole 4Interleukin-2 4Drug Therapy 4Doxorubicin 4Albumin-Bound Paclitaxel 4rucaparib 3fludarabine 3chiauranib 3cemiplimab 3camrelizumab 3Therapeutics 3Itraconazole 3Injections 3Hyperthermic Intraperitoneal Chemotherapy 3Everolimus 3pazopanib 2iniparib 2eprenetapopt 2avelumab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recurrence × Docetaxel × Gynecologic × Clear all
NCT00231855 2012-04-24

Efficacy Study of Weekly Taxotere and Topotecan for Recurrent Gynecologic (GYN) Cancers

Montefiore Medical Center

Phase 2 Completed
31 enrolled
Gynecologic

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms, Recurrence, Uterine Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡